| 标题 |
Risk factors for progression to blast phase and outcome in 589 patients with myelofibrosis treated with ruxolitinib: Real-world data |
| 网址 | |
| DOI | |
| 其它 |
期刊:Hematological oncology 作者:Palandri F; Breccia M; Tiribelli M; Bonifacio M; Benevolo G; et al 出版日期:2020/08/01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)